Literature DB >> 7759173

Methadone dosing and pregnancy: impact on program compliance.

P B DePetrillo1, J M Rice.   

Abstract

A retrospective, inception cohort, nonrandomized control design was employed to evaluate the effects of daily vs twice daily dosing of methadone on opiate/cocaine use, and noncompliance with urine toxicology requests in methadone-maintained pregnant women, n = 45. Earlier program entry was associated with decreased opiate and cocaine use and increased compliance with urinalysis requests. The single dose and split-dose groups differed in urine toxicology compliance rates, 23.8 vs 0.5%, as well as percentages of urines positive for cocaine, 15.3 vs 0.3%, only in Trimester III.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7759173     DOI: 10.3109/10826089509060743

Source DB:  PubMed          Journal:  Int J Addict        ISSN: 0020-773X


  6 in total

1.  Cocaine and opioid use during pregnancy: prevalence and management.

Authors:  Chaya G Bhuvaneswar; Grace Chang; Lucy A Epstein; Theodore A Stern
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

2.  Maternal methadone dosing schedule and fetal neurobehaviour.

Authors:  Lauren M Jansson; Janet A Dipietro; Martha Velez; Andrea Elko; Heather Knauer; Katie T Kivlighan
Journal:  J Matern Fetal Neonatal Med       Date:  2009-01

3.  Dosing and monitoring of methadone in pregnancy: literature review.

Authors:  Jennifer R Shiu; Mary H H Ensom
Journal:  Can J Hosp Pharm       Date:  2012-09

Review 4.  Treatment of opioid-dependent pregnant women: clinical and research issues.

Authors:  Hendree E Jones; Peter R Martin; Sarah H Heil; Karol Kaltenbach; Peter Selby; Mara G Coyle; Susan M Stine; Kevin E O'Grady; Amelia M Arria; Gabriele Fischer
Journal:  J Subst Abuse Treat       Date:  2008-01-14

5.  Opioid use disorder in pregnancy.

Authors:  Kristin Harter
Journal:  Ment Health Clin       Date:  2019-11-27

6.  The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data.

Authors:  W O Farid; S A Dunlop; R J Tait; G K Hulse
Journal:  Curr Neuropharmacol       Date:  2008-06       Impact factor: 7.363

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.